Online Appendix for the following JACC article
TITLE: The New York State Cardiac Registries: History, Contributions, Limitations and
Lessons for Future Efforts to Assess and Publicly Report Health Care Outcomes
AUTHORS: Edward L. Hannan, PHD, Kimberly Cozzens, MA, Spencer B. King III,
MD, Gary Walford, MD, Nirav R. Shah, MD
APPENDIX
Supplementary References
1. Hannan EL, Wu C, Walford G, et al. Volume-outcome relationships for percutaneous
coronary interventions in the stent era. Circulation 2005;112:1171-1179.
2. Wu C, Hannan EL, Ryan TJ, et al. Is the impact of hospital and surgeon volumes on in
hospital mortality rate for coronary artery bypass graft surgery limited to patients of high
risk? Circulation 2004:110(7):784-789.
3. Hannan EL, Wu C, Ryan TJ, et al. Do hospitals and surgeons with higher CABG
surgery volumes still experience lower risk-adjusted mortality rates? Circulation
2003;108:795-801.
4. Hannan EL, Racz M, Kavey R-E, Quaegebeur JM, Williams R. Pediatric cardiac
surgery: The effect of hospital and surgeon volume on in-hospital mortality. Pediatrics
1998;101(6):963-969.
5. Hannan EL, Racz M, Ryan TJ, et al. Coronary angioplasty volume-outcome
relationships for hospitals and cardiologists. JAMA 1997;277(11):892-898.
6. Hannan EL. Percutaneous coronary interventions: Heed the ACC volume
recommendations, but strive to improve quality. J Am Coll Cardiol 1999;34(5):14811483.
7. Hannan EL, The relation between volume and outcome in health care. N Engl J Med
1999;56(3):1677-1679.
8. Glance LG, Dick AW, Mukamel DB, Osler TM. Is the hospital volume-mortality
relationship in coronary artery bypass surgery the same for low-risk vs. high-risk
patients? Ann Thorac Surg 2003;76(4):1155-1162.
9. Glance LG, Dick AW, Osler TM, Mukamel DB. The relation between surgeon volume
and outcome following off-pump vs. on-pump coronary artery bypass graft surgery.
Chest 2005;128(2):829-837.
10. Hannan EL, Kilburn H Jr, Bernard H, O'Donnell, Lukacik, Shields EP. Coronary
artery bypass surgery: The relationship between in-hospital mortality rate and surgical
volume after controlling for clinical risk factors. Med Care 1991;29(11):1094-1107.
11. Hannan EL, Zhong Y, Lahey SJ,, et al. Thirty-day readmissions following CABG
surgery in New York. J Am Coll Cardiol Intv. In press.
12. Hannan EL. Readmissions for CABG surgery: An important supplemental outcome.
Italian Heart J 2003;4(11):735-738.
2
13. Hannan EL, Racz MJ, Walford G, Ryan TJ, Isom OW, Bennett E, Jones RH.
Predictors of readmission for complications of coronary artery bypass graft surgery in
New York State. JAMA 2003;290:773-780.
14. Hannan EL, Samadashvili, Z, Walford G, et al. Comparison of outcomes for patients
receiving drug-eluting vs. bare-metal stents for non-ST elevation myocardial infarction.
Am J Cardiol 2011;107(9):1311-1318.
15. Kirtane AJ, Gupta A, Iyengar S, et al. Safety and efficacy of drug-eluting and bare
metal stents: Comprehensive meta-analysis of randomized trials and observational
studies. Circulation 2009;119(25):3198-3206.
16. Hannan EL, Racz MJ, Holmes DR, et al. A Comparison of coronary artery stenting
outcomes in the eras before and after the introduction of drug-eluting stents. Circulation
2008;117:2071-2078.
17. Hannan EL, Racz M, Holmes DR, et al. A comparison of mortality, myocardial
infarction and repeat revascularization for sirolimus-eluting and paclitaxel-eluting
coronary stents. Am Heart J 2007;154(3):545-553.
18. Hannan EL, Racz MJ, Arani DT, McCallister BD, Walford G, Ryan TJ. A
comparison of short- and long-term outcomes for balloon angioplasty and coronary stent
placement. J Am Coll Cardiol 2000;36(2):395-403.
19. Hannan EL, Wu C, Walford G, et al. Incomplete revascularization in the era of drugeluting stents: Impact on adverse outcomes. J Am Coll Cardiol Intv 2009;2;26-35.
20. Hannan EL, Racz M, Holmes DR, et al. The impact of completeness of
revascularization on long-term outcomes in the stent era. Circulation 2006;113(20):24062412.
3
21. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. CABG in multivessel
coronary disease. N Engl J Med 2008;358:331-341.
22. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes for coronary artery
bypass graft surgery vs. stent implantation. N Engl J Med 2005;352(21):2174-2183.
23. Hannan EL, Racz MJ, McCallister BD, et al. A comparison of three-year survival
following coronary artery bypass graft surgery and percutaneous transluminal coronary
angioplasty. J Am Coll Cardiol 1999;33(1):63-72.
24. Wu C, Hannan EL, Walford G, Faxon DP. Utilization and outcomes of unprotected
left main coronary artery stenting and coronary artery bypass graft surgery. Ann Thorac
Surg 2008;86:1153-1159.
25. Hannan EL, Wu C, Smith CR, et al. Off-Pump vs. on-pump CABG surgery:
Differences in short-term outcomes and in long-term mortality and need for subsequent
revascularization. Circulation 2007;116(10)1145-1152.
26. Racz MA, Hannan EL, Isom OW, et al. A comparison of short and long-term
outcomes following off-pump and on-pump coronary artery bypass graft surgery with
sternotomy. J Am Coll Cardiol 2004;43;557-564.
27. Hannan EL, Wu C, Bennett EV, et al. A risk index for predicting in-hospital mortality
for cardiac valve surgery. Ann Thorac Surg 2007;83:921-930.
28. Hannan EL, Wu C, Bennett EV, et al. Risk stratification of in-hospital mortality for
coronary artery bypass graft surgery. J Am Coll Cardiol 2006;47(3):661-668.
29. Wu C, Hannan EL, Walford G, et al. A risk score to predict in-hospital mortality for
percutaneous coronary interventions. J Am Coll Cardiol 2006;47(3):654-660.
4
30. Hannan EL, Racz M, Walford G, et al. Differences in utilization of drug-eluting stents
by race and payer. Am J Cardiol 2007;100(8):1192-1198.
31. Hannan EL, van Ryn M, Burke J, et al. Access to coronary artery bypass surgery by
race/ethnicity and gender among patients who are appropriate for surgery. Med Care
1999;37(1):68-77.
32. Hannan EL, Kilburn H Jr., O'Donnell JF, Lukacik G, Shields EP. Interracial access to
selected cardiac procedures for patients hospitalized with coronary artery disease in New
York State. Med Care 1991;29(5):430-441.
33. Hannan EL, Samadashvili Z, Lahey SJ, et al. Predictors of post-operative hematocrit
and association of hematocrit with adverse outcomes for coronary artery bypass graft
surgery patients with cardiopulmonary bypass, J Card Surg 2010;26:636-646.
34. Hannan EL, Samadashvili Z, Wechsler A, et al. The relationship between
perioperative temperature and adverse outcomes following off-pump coronary artery
bypass graft surgery. J Thorac Cardiovasc Surg 2010;139(6):1568-1575.
35. Hannan EL, Samadashvili Z, Walford G, et al. Culprit vessel vs. multivessel and
staged PCI for ST-Elevation myocardial infarction patients with multivessel disease. J
Am Coll Cardiol Intv 2010;3:22-31.
36. Hannan EL, Samadashvili Z, Walford G, et al. Predictors and outcomes of ad hoc vs.
non-ad hoc percutaneous coronary interventions, J Am Coll Cardiol Intv 2009;2;350-356.
37. Hannan EL, Zhong Y, Jacobs AK, et al. Impact of onset-to-door time and door-toballoon time on mortality for ST-elevation myocardial infarction undergoing
percutaneous coronary interventions. Am J Cardiol 2010;106:143-147.
5
38. Cowper PA, DeLong ER, Hannan EL, et al. Is early too early: Effects of shorter stay
following bypass surgery. Ann Thorac Surg 2007;83(1):100-107.
39. Cowper PA, DeLong ER, Hannan EL, et al. Trends in postoperative length of stay
following bypass surgery. Am Heart J 2006;152(6):1194-1200.
40. Goldstein CL, Hannan EL, Racz M. The impact of cardiac catheterization-PCI timing
on in-hospital mortality. Am Heart J 2002;144:561-567.
41. Hannan EL, Zhong Y, Racz M, et al. Outcomes for patients with ST-elevation
myocardial infarction in hospitals with and without onsite coronary artery bypass graft
surgery. Circ Cardiovasc Interv 2009;2(6):519-527.
42. Hannan EL. Evaluating and improving the quality of care for acute myocardial
infarction: Can regionalization help? JAMA 2006;295;18:2177-2179.
43. Rosenthal GE, Sarrazin MV, Hannan EL. In-hospital mortality following coronary
artery bypass graft surgery in Veterans Health Administration and private sector
hospitals. Med Care 2003;41(4):522-535.
44. Sarrazin MSV, Hannan EL, Rosenthal GE. Mortality in Medicare Beneficiaries
following coronary artery bypass graft surgery in states with and without certificate of
need regulation. JAMA 2002;288:1859-1866.
45. Erickson LC, Torchiana DF, Schneider EC, Newburger JW, Hannan EL. The
relationship between managed care insurance and the use of lower mortality hospitals for
CABG surgery. JAMA 2000;283(15):1976-1982.
46. Ko DT, Tu JV, Samadashvili Z, et al. Temporal trends in the use of percutaneous
coronary intervention and coronary artery bypass surgery in New York State and Ontario.
Circulation 2010;121:2635-2644.
6
47. Hannan EL, Wu C, Chassin MR. Differences in per capita rates of revascularization
and in choice of revascularization procedure for eleven states. BMC Health Services Res
2006;6:35.
48. Hannan EL, Kumar D, and the IHD PORT. Geographic variation in the utilization
and choice of procedures for treating coronary artery disease in New York State. J Health
Services Res Pol 1997;2(3):137-143.
49. Tu JV, Naylor CD, Kumar D, DeBuono BA, McNeil BJ, Hannan EL. Coronary
artery bypass surgery in Ontario and New York State: Which rate is right? Ann Intern
Med 1997;126(1):13-19.
50. Hannan EL, Samadashvili Z, Lahey SJ, et al. Aortic valve replacement for patients
with severe aortic stenosis: Risk factors and their impact on 30-month mortality. Ann
Thorac Surg 2009;87(6):1741-1749.
51. van Gameren M, Venema1 AC, Hannan EL, et al. Do we need a separate risk
stratification model for hospital mortality after heart valve surgery? Ann Thorac Surg
2008;85:921-931.
52. Szczech LA, Reddan DN, Owen WF Jr., et al. Differential survival following
coronary revascularization among patients with renal insufficiency. Kidney Int
2001;60:292-299.
53. Hannan EL, Racz MJ, Jones RH, et al. Predictors of mortality for patients undergoing
cardiac valve replacements in New York State. Ann Thorac Surg 2000;70(4):1212-1218.
54. Block PC, Peterson ED, Krone R, et al. Identification of variables needed to riskadjust outcomes of coronary interventions: Evidence-based guidelines for efficient data
collection. J Am Coll Cardiol 1998;32(1):275-282.
7
55. Jones RH, Hannan EL, Hammermeister KE, et al. Identification of preoperative
variables needed to risk-adjust short-term mortality after coronary artery bypass grafting.
J Am Coll Cardiol 1996;28:1478-1487.
56. Hannan EL, Burke J. Effect of age on mortality in coronary artery bypass surgery in
New York State: 1991-1992. Am Heart J 1994;128(6):1184-1191.
57. Hannan EL, Bernard HR, Kilburn HC, O'Donnell JF. Gender differences in mortality
rates for coronary artery bypass surgery. Am Heart J 1992;123(4):866-872.
58. Hannan EL, Kilburn H Jr., O'Donnell JF, Lukacik G, Shields EP. Adult open heart
surgery in New York State: An analysis of risk factors and hospital mortality rates.
JAMA 1990;264(21):2768-2774.
59. Hannan EL, Arani DT, Johnson LW, Kemp HG, Lukacik G. Percutaneous
transluminal coronary angioplasty in New York State from 1/1/91 to 6/30/91: Risk
factors and outcomes for 5827 patients in 30 hospitals. JAMA 1992;268(21):3092-3097.
60. Hannan EL, Racz MJ, Arani DT, Ryan TJ, Walford G, McCallister BD. Short- and
long-term mortality for patients undergoing primary angioplasty for acute myocardial
infarction. J Am Coll Cardiol 2000;36(4):1194-1201.
61. Hannan EL, Wu C, DeLong ER, Raudenbush SW. Predicting risk-adjusted mortality
for CABG Surgery: Logistic vs. hierarchical logistic models. Med Care 2005;43:726-735.
62. Weeks WB, Bazos DM, Bott DM, et al. New York’s statistical model accurately
predicts mortality risk for veterans who obtain private sector care. Health Services Res
2005;40(4):1186-1196.
63. Hannan EL, Wu C. Assessing quality and outcomes for PCI: Choosing statistical
models, outcomes, time periods, and patient populations, Am Heart J 2003;145:571-574.
8
64. Weller WE, Kabra G, Cozzens KS, Hannan EL. Appending limited clinical data to an
administrative database for assessing institutional quality outliers for AMI care: Does it
matter? Int J Cardiol 2008 Nov 25 [E-pub ahead of print].
65. Hannan EL. Randomized clinical trials and observational studies: Guidelines for
assessing respective strengths and limitations. J Am Coll Cardiol Intv 2008;1(3):211-217.
66. Hannan EL, Racz MJ, Gold J, et al. Adherence of catheterization laboratory
cardiologists to ACC/AHA guidelines for percutaneous coronary interventions and
CABG surgery: What happens in actual practice? Circulation 2010,121: 267–275.
67. Doran DR, Roark CS, Hannan EL. Improving quality of care for pediatric cardiac
surgery in New York State. Prog Pediatr Cardiol 2003;18(1):13-25.
9